- Home
- FBRX vs BTQ Comparison
FBRX vs BTQ Comparison
Compare FBRX & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | BTQ |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 831.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | BTQ |
|---|---|---|
| Price | $56.63 | $3.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $67.00 | $10.00 |
| AVG Volume (30 Days) | 824.3K | ★ 4.6M |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | $2,332.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.25 | $2.09 |
| 52 Week High | $52.67 | $16.00 |
Technical Indicators
Market Signals| Indicator | FBRX | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 86.71 | 39.27 |
| Support Level | $24.72 | $2.23 |
| Resistance Level | N/A | $3.84 |
| Average True Range (ATR) | 5.30 | 0.36 |
| MACD | 2.32 | -0.12 |
| Stochastic Oscillator | 99.06 | 12.80 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About BTQ BTQ Technologies Corp.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.